July 2019 Br J Cardiol 2019;26:92–6 doi:10.5837/bjc.2019.026
Subodh R Devabhaktuni, Ali O Malik, Ji Won Yoo, Xibei Liu, Vipul Shah, Syed I Shah, John M Ham, Bejon T Maneckshana, Jimmy Diep, Chowdhury H Ahsan
Introduction Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with end-stage renal disease (ESRD), and in those after renal transplant.1,2 The pre-operative cardiovascular risk assessment is critical prior to renal transplant surgery to ensure appropriate patient selection, and to prevent adverse effects on one- and three-year patient and graft survival. In addition, these patients are closely monitored for over three years and any events are reported to the United Network for Organ Sharing. The pre-operative assessment is done based on the American Heart Association and the American College of Cardiolo
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits